{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:41:26Z","timestamp":1793749286664,"version":"4.6.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015519","name":"Caen Normandie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015519","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lungcan.2026.109545","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:16:43Z","timestamp":1785071803000},"page":"109545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clinicopathological and prognostic validation of pulmonary carcinoid\/NET G3: evidence for a distinct subgroup of well-differentiated neuroendocrine neoplasms"],"prefix":"10.1016","volume":"219","author":[{"given":"Jules","family":"Kirmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6011-2381","authenticated-orcid":false,"given":"Marc","family":"Riffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bazille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9025-6768","authenticated-orcid":false,"given":"Marie-Laure","family":"Quintyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6166-0366","authenticated-orcid":false,"given":"Ga\u00ebtane","family":"Planchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1148-7497","authenticated-orcid":false,"given":"Fatemeh","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Jean-Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lungcan.2026.109545_b0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12022-026-09914-2","article-title":"Well-differentiated neuroendocrine tumors of lung: a case series supporting the IARC\/WHO common classification of neuroendocrine tumor nomenclature and grading","volume":"37","author":"Altun","year":"2026","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.lungcan.2026.109545_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2026.103977","article-title":"IASLC update on classification of pulmonary neuroendocrine neoplasms","author":"Beasley","year":"2026","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109545_b0015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/his.14819","article-title":"Lung carcinoid tumours: histology and Ki-67, the eternal rivalry","volume":"82","author":"Centonze","year":"2023","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109545_b0020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11547-022-01494-5","article-title":"Radiomics in pulmonary neuroendocrine tumours (NETs)","volume":"127","author":"Cozzi","year":"2022","journal-title":"Radiol. Med."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109545_b0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1530\/ERC-21-0109","article-title":"Treatment outcomes of advanced digestive well-differentiated grade 3 NETs","volume":"28","author":"de Mestier","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"issue":"16","key":"10.1016\/j.lungcan.2026.109545_b0030","article-title":"Evidence for the transformation of a subset of pulmonary carcinoids to small cell lung carcinomas through shared molecular alterations","volume":"20","author":"Fan","year":"2026","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109545_b0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000495806","article-title":"Clinicopathological profiling of lung carcinoids with a Ki67 Index > 20","volume":"108","author":"Kasajima","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109545_b0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00428-021-03202-6","article-title":"An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features","volume":"480","author":"Kasajima","year":"2022","journal-title":"Virchows. Arch."},{"key":"10.1016\/j.lungcan.2026.109545_b0045","series-title":"WHO Classification Od Tumours Editorial Board","first-page":"16","article-title":"Classification of neuroendocrine neoplasms of the digestive system","author":"Klimstra","year":"2019"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109545_b0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12022-023-09755-3","article-title":"Diagnostic, prognostic, and predictive role of Ki67 proliferative index in neuroendocrine and endocrine neoplasms: past, present, and future","volume":"34","author":"La Rosa","year":"2023","journal-title":"Endocr Pathol."},{"issue":"6)","key":"10.1016\/j.lungcan.2026.109545_b0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00428-017-2177-0","article-title":"Distinctive pathological and clinical features of lung carcinoids with high proliferation index","volume":"471","author":"Marchi\u00f2","year":"2017","journal-title":"Virchows Arch."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109545_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100677","article-title":"OTP, CD44, and Ki-67: A prognostic marker panel for relapse-free survival in patients with surgically resected pulmonary carcinoid","volume":"38","author":"Moonen","year":"2025","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109545_b0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.lungcan.2026.109545_b0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031531","article-title":"The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis","volume":"9","author":"Naheed","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109545_b0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12022-026-09920-4","article-title":"Three-tier prognostic stratification of lung carcinoids (NET G1-G2-G3) by multivariable, data-driven integration of Ki-67 and mitotic count","volume":"37","author":"Orlando","year":"2026","journal-title":"Endocr. Pathol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109545_b0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/his.15206","article-title":"Head-to-head: should Ki67 proliferation index be included in the formal classification of pulmonary neuroendocrine neoplasms?","volume":"85","author":"Pelosi","year":"2024","journal-title":"Histopathology"},{"issue":"Suppl 1","key":"10.1016\/j.lungcan.2026.109545_b0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41379-021-00943-2","article-title":"Lung neuroendocrine neoplasms: recent progress and persistent challenges","volume":"35","author":"Rekhtman","year":"2022","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2026.109545_b0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.lungcan.2020.08.001","article-title":"Lung carcinoids with high proliferative activity: further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms","volume":"148","author":"Rubino","year":"2020","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109545_b0095","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/cancers16030502","article-title":"Prognostic thresholds of mitotic count and Ki-67 labeling index for recurrence and survival in lung atypical carcinoids","volume":"16","author":"Soldath","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109545_b0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/his.15058","article-title":"Updates on lung neuroendocrine neoplasm classification","volume":"84","author":"Vocino Trucco","year":"2024","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109545_b0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12022-021-09668-z","article-title":"Molecular pathology of well-differentiated pulmonary and thymic neuroendocrine tumors: what do pathologists need to know?","volume":"32","author":"Volante","year":"2021","journal-title":"Endocr. Pathol."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109545_b0110","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/his.14277","article-title":"Challenges in Ki-67 assessments in pulmonary large-cell neuroendocrine carcinomas","volume":"78","author":"Walts","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.lungcan.2026.109545_b0115","series-title":"Thoracic tumours: WHO classification of tumours","author":"WHO Classification of Tumours Editorial Board","year":"2021"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:25:59Z","timestamp":1791271559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":23,"alternative-id":["S0169500226006069"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109545","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological and prognostic validation of pulmonary carcinoid\/NET G3: evidence for a distinct subgroup of well-differentiated neuroendocrine neoplasms","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109545"}}